Latest news
Ligand Pharmaceuticals Inc (LGND) (Q2 2026) Earnings Call Highlights: Royalty Revenue Surges ... - Yahoo! Finance CanadaYahoo! Finance Canada · Thu, 06 Aug 2026 23:18:35 GMTLigand Pharmaceuticals Incorporated Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 22:40:40 GMTLigand Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 21:03:55 GMT(LGND) Ligand Pharmaceuticals Expects 2026 Adjusted EPS Range $9.00 to $9.50, vs. FactSet Est of $9.21 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 12:07:37 GMTLigand Reports Second Quarter 2026 Financial Results - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 11:19:22 GMT